In vitro metabolism of R(+)-[2,3-dihydro-5-methyl-3-[(morpholinyl)methyl] pyrrolo [1,2,3-de]1,4-benzoxazinyl]-(1-naphthalenyl) methanone mesylate, a cannabinoid receptor agonist

Drug Metabolism and Disposition

Volumn 30, Issue 10, 2002, Pages 1077-1086

  Zhang, Qiang ^a   Peng, Ma ^b   Iszard, Marcus ^b   Cole, Richard B ^a   Wang, Weiqun ^a   Wang, Guangdi ^b  

^a College of Pharmacy   (United States)

^b XAVIER UNIVERSITY OF LOUISIANA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; CANNABINOID RECEPTOR AGONIST;

ANIMAL TISSUE; ARTICLE; DRUG METABOLISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROGENATION; LIVER MICROSOME; MASS SPECTROMETRY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; RAT;

ANIMALS; CANNABINOIDS; MICROSOMES, LIVER; MORPHOLINES; NAPHTHALENES; RATS; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; STRUCTURE-ACTIVITY RELATIONSHIP;

ANIMALIA; ARENE;

EID: 0036784480     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: 10.1124/dmd.30.10.1077     Document Type: Article

References (18)

1. Aceto MD, Scates SM, and Martin BB (2001) Spontaneous and precipitated withdrawal with a synthetic cannabinoid, WIN 55212-2. Eur J Pharmacol 416:75-81.
2. Agurell S, Halldin M, Lindgren J, Ohlsson A, Widman M, Gillespie H, and Hollister L (1986) Pharmacokinetics and metabolism of Δ1-tetrahydrocannabinol and other cannabinoids with emphasis on man. Pharmacol Rev 38:21-43.
3. Bell MR, D'Ambra TE, Kumar V, Eissenstat MA, and Hermann JL (1991) Antinociceptive (aminoalkyl)-indoles. J Med Chem 34:1099-1110.
4. Bridges D, Ahmad K, and Rice AS (2001) The synthetic cannabinoid WIN55212-2 attenuates hyperalgesia and allodynia in a rat model of neuropathic pain. Br J Pharmacol 133:586-594.
5. Daly JW, Jerina DM, and Witkop B (1972) Arene oxides and the NIH shift: the metabolism. toxicity and carcinogenicity of aromatic compounds. Experientia 28:1129-1149.
6. D'Ambra TE, Estep KG, Bell MR, Eissenstat MA, Josef KA, Ward SJ, Haycock DA, Baizman ER, Casiano FM, Beglin NC, et al. (1992) Conformationally restrained analogues of pravadoline: nanomolar potent, enantioselective, (aminoalkyl)indole agonists of the cannabinoid receptor. J Med Chem 35:124-135.
7. Eissenstat MA, Bell MR, D'Ambra TE, Alexander EJ, Daum SJ, Ackerman JH, Gruett MD, Kumarm V, Estep KG, Olefirowicz EM, et al. (1995) Aminoalkylindoles: structure-activity relationships of novel cannabinoid mimetics. J Med Chem 38:3094-3105.
8. Gardiner SM, March JE, Kemp PA, and Bennett T (2001) Regional haemodynamic responses to the cannabinoid agonist, WIN 55212-2, in conscious, normotensive rats and in hypertensive, transgenic rats. Br J Pharmacol 133:445-453.
9. Guroff G, Daly J, Jerina DM, Renson J, Witkop B, and Udenfreind S (1967) Hydroxylation-induced migration: the NIH shift. Science (Wash DC) 157:1524-1530.
10. Harvey DJ (1999) Absorption, distribution and biotransformation of the cannabinoids, in Marihuana Med (Nahas GG ed) pp 91-103, Humana, Totowa, New Jersey.
11. Harvey DJ and Paton WDM (1984) Metabolism of the cannabinoids. Rev Biochem Toxicol 6:221-264.
12. Jerina D, Daly J, Witkop B, Zaltzman-Nirenberg P, and Udenfreind S (1968) Role of the arene oxide-oxepin system in the metabolism of aromatic substrates. I. In vitro conversion of benzene oxide to a premercapturic acid and a dihydrodiol. Arch Biochem Biophys 128:176-183.
13. Kuster JE, Stevenson JI, Ward SJ, D'Ambra TE, and Haycock DA (1992) Aminoalkylindole binding in rat cerebellum: selective displacement by natural and synthetic cannabinoids. J Pharmacol Exp Ther 264:1352-1363.
14. Madyastha KM and Gaikwad NW (1999) Metabolic disposition of a monoterpene ketone, piperitenone, in rats: evidence for the formation of a known toxin, p-cresol. Drug Metab Dispos 27:74-80.
15. Pacheco M, Childers SR, Arnold R, Casiano F, and Ward SJ (1990) Actions on specific G-protein-linked receptors. J Pharmacol Exp Ther 257:170-183.
16. Simoneau II, Hamza MS, Mata HP, Siegel EM, Vanderah TW, Porreca F, Makriyannis A, and Malan TP (2001) The cannabinoid agonist WIN55212-2 suppresses opioid-induced emesis in ferrets. Anesthesiology 94:882-887.
17. Song ZJ and Slowey CA (1998) Involvement of cannabinoid receptors in the intraocular pressure-lowering effects of WIN55212-2. J Pharmacol Exp Ther 292:136-139.
18. Ward SJ, Baizman ER, Bell MR, Childers S, D'Ambra TE, Eissenstat MA, Estep KG, Haycock DA, Howlett A, Luttinger D, et al. (1990) (Aminoalkyl) indoles (AAIs): a new route to the cannabinoid receptor? NIDA Res Monogr 105:425-426.